Simplification of Rabies Postexposure Prophylaxis: A New 2-Visit Intradermal Vaccine Regimen

Area of Science:

• Vaccinology
• Public Health
• Infectious Disease Control

Background:

• Postexposure prophylaxis (PEP) for rabies is crucial, but traditional methods face challenges in resource-limited settings.
• Intradermal (ID) vaccination offers a more economical alternative, yet its implementation has been hindered by complex protocols.
• Existing World Health Organization (WHO) recommendations for ID rabies PEP, while improved, may not be cost-effective in areas with limited vaccine availability.

Purpose of the Study:

• To evaluate a simplified, 2-visit, multiple-site intradermal (ID) vaccine protocol for rabies postexposure prophylaxis (PEP).
• To determine the economic viability and practicability of this ID regimen for clinics with low patient throughput.
• To advocate for the adoption of this optimized ID protocol in new global health initiatives for rabies prevention.

Main Methods:

• A 2-visit protocol involving intradermal (ID) administration of rabies vaccine.
• Day 1: Full vial divided among 4 ID injection sites.
• Day 7: Half vial divided among 2 ID injection sites, with an optional Day 28 dose.

Main Results:

• The 2-visit, 4-site ID regimen is identified as the most economical, immunogenic, and practicable approach for PEP.
• This protocol aligns with updated WHO recommendations, including those with a Day 28 dose.
• The simplified ID protocol addresses previous difficulties, potentially improving prophylaxis access in rural Asia and Africa.

Conclusions:

• The described 2-visit, 4-site ID rabies PEP regimen offers a cost-effective and practical solution for clinics with limited patient numbers.
• This protocol should be strongly considered for implementation in new rabies prevention initiatives, such as those supported by Gavi.
• Wider adoption of this simplified ID strategy can significantly enhance global postexposure rabies prophylaxis delivery.